An agarose-alginate microfluidic device for the study of spheroid invasion, ATRA inhibits CAFs-mediated matrix

Mohammad Reza Nasiraee1, Shabnam Shahrivari1, Soheila Sayad2

  • 1Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran 1449614535, Iran.

Cytotechnology
|June 30, 2023
PubMed

Insights

All-trans retinoic acid (ATRA) effectively normalized cancer-associated fibroblast (CAF) functions in a 3D tumor model. ATRA reduced cancer cell invasion within CAF-derived matrices, suggesting a therapeutic strategy for normalizing CAFs.

Area of Science:

  • Oncology
  • Biomaterials Science
  • Cancer Biology

Background:

  • Cancer-associated fibroblasts (CAFs) drive tumor progression, metastasis, and treatment resistance.
  • Targeting CAF proliferative functions offers a potential therapeutic strategy for cancer control.
  • Multicellular spheroids within microfluidic systems provide realistic tumor microenvironment (TME) models.

Purpose of the Study:

  • To investigate the effect of all-trans retinoic acid (ATRA) on 3D spheroid invasion within a CAF-derived extracellular matrix (ECM) hydrogel.
  • To evaluate ATRA's potential for normalizing CAF functions in a tumor model.
  • To assess the utility of microfluidic systems with CAF-ECM hydrogels for studying anti-cancer agents.

Main Methods:

  • Utilized an agarose-alginate microfluidic chip for spheroid culture.
  • Incorporated CAF-derived ECM into a hydrogel matrix to simulate the TME.
  • Exposed MDA-MB cell spheroids within the CAF-ECM hydrogel to all-trans retinoic acid (ATRA).

Main Results:

  • ATRA treatment significantly reduced the number of invasive cells in the CAF-ECM hydrogel (p < 0.05).
  • This reduction indicates a potential for ATRA to normalize CAF behavior.
  • The hydrogel casting method proved simpler and more cost-effective for chip fabrication.

Conclusions:

  • All-trans retinoic acid (ATRA) demonstrates efficacy in normalizing cancer-associated fibroblast (CAF) functions within a 3D tumor model.
  • ATRA treatment reduces cancer cell invasion, highlighting its therapeutic potential.
  • Microfluidic systems with CAF-ECM hydrogels offer a viable and cost-effective platform for evaluating anti-cancer therapies targeting CAFs.

Related Concept Videos